Drug industry can profit from clinical-trial data openness, say leading regulators - Nature.com (blog) | Pharma Industry | Scoop.it
“Drug industry can profit from clinical-trial data openness, say leading regulators Nature.com (blog) The drug industry's opposition to greater access to clinical trial data is misplaced, four senior figures in the European Medicines Agency (EMA)...”